Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|August 18, 2018
Identification of non-mutated neoantigens presented by TAP-deficient tumorsKoen A Marijt, Laura Blijleven, Els M E Verdegaal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Characterization of antigen-specific immune responses induced by canarypox virus vaccinesRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2013
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentationCláudia C Oliveira, Bianca Querido, Marjolein Sluijter, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumorsElham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas, et al.
Journal for Immunotherapy of Cancer|October 21, 2020
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapyChristianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, et al.
International Journal of Molecular Sciences|August 12, 2022
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 AntibodyMarit J van Elsas, Johan M S van der Schoot, Alexander Bartels, et al.
Cancer Immunology Research|April 17, 2020
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future TumorsGreta Garrido, Brett Schrand, Agata Levay, et al.
Investigative Ophthalmology & Visual Science|January 25, 2024
Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma ModelSen Ma, Ruben V Huis In't Veld, Yang Hao, et al.
Plos One|May 8, 2012
Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cellsMarvin M van Luijn, Arjan A van de Loosdrecht, Margit H Lampen, et al.
International Journal of Cancer|December 17, 2009
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumorsMinka van Dongen, Nigel D L Savage, Ekaterina S Jordanova, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|August 18, 2018
Identification of non-mutated neoantigens presented by TAP-deficient tumorsKoen A Marijt, Laura Blijleven, Els M E Verdegaal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Characterization of antigen-specific immune responses induced by canarypox virus vaccinesRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2013
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentationCláudia C Oliveira, Bianca Querido, Marjolein Sluijter, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumorsElham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas, et al.
Journal for Immunotherapy of Cancer|October 21, 2020
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapyChristianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, et al.
International Journal of Molecular Sciences|August 12, 2022
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 AntibodyMarit J van Elsas, Johan M S van der Schoot, Alexander Bartels, et al.
Cancer Immunology Research|April 17, 2020
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future TumorsGreta Garrido, Brett Schrand, Agata Levay, et al.
Investigative Ophthalmology & Visual Science|January 25, 2024
Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma ModelSen Ma, Ruben V Huis In't Veld, Yang Hao, et al.
Plos One|May 8, 2012
Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cellsMarvin M van Luijn, Arjan A van de Loosdrecht, Margit H Lampen, et al.
International Journal of Cancer|December 17, 2009
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumorsMinka van Dongen, Nigel D L Savage, Ekaterina S Jordanova, et al.
Pageof 13